MD

Mark De Souza

North America, California, United States, Berkeley

Description

Mark de Souza is the President and CEO of SonALAsense. He previously worked at Willow Neuroscience as a Co-Founder, President.

Investor Profile

Mark De Souza has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mark De Souza frequently co-invest with?

Toba Capital
North America, California, United States, San Francisco
Co-Investments: 1
Alchimia Investments
Europe, Lazio, Italy, Rome
Co-Investments: 1
Civilization Ventures
North America, California, United States, San Francisco
Co-Investments: 1
ZG
North America, California, United States, San Francisco
Co-Investments: 1
Valia Ventures
North America, New York, United States, New York
Co-Investments: 1
Viking Global Investors
North America, Connecticut, United States, Stamford
Co-Investments: 1
Start Capital
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Mark De Souza?

DermBiont

Boston, Massachusetts, United States

DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.

BiotechnologyHealth CareMedicalTherapeutics
Series AJun 18, 2019
Amount Raised: $8,000,000